Leveraging this resource [the Systeme National des Donnees de Sante (SNDS)], we conduct numerous real-world studies, positioning France among the leaders in real-world evidence generation within…
In Conversation
[We must] avoid placing AI at the centre and then working backwards to find a problem. Instead, we should take a problem-centric approach, identifying real-world challenges…
The funding landscape for science in Portugal is facing challenges that stem from a decrease in overall investment and shifting priorities. Despite the evident role of…
Our broad, global portfolio includes products that help treat the top 10 leading causes of death globally, as determined by the WHO
We are committed to finding a balanced approach that considers both the imperative of enabling better health outcomes and the need for ensuring the sustainability of…
My vision for the presidency is centered on instilling pride within hospital pharmacists, encouraging a sense of accomplishment in their crucial role
It's crucial for all stakeholders, from promoters to investors, to comprehend the unique challenges and opportunities presented by the blue economy. The sector's success lies not…
My management style is based on betting everything on the people we have. I believe that having an efficient, motivated, and engaged team that works cross-functionally…
Our approach is characterized by collaboration and flexibility. We engage closely with our clients to comprehend their unique requirements and adapt our global offer accordingly. This…
I am optimistic that diabetes care will improve. The inequality of care in Europe and Portugal exists, and it is really important to plan how we…
A collaborative environment … can potentially position Portugal on par with Spain in the clinical research landscape within the next five years
One of the pivotal aspects that we emphasise when engaging with international stakeholders is Portugal's robust scientific network and the quality of its scientific research
